AdipoGen animal-free recombinant monoclonal antibodies (RecMAbs)

Monday, 26 August, 2019 | Supplied by: Sapphire Bioscience

AdipoGen develops recombinant monoclonal antibodies (RecMAbs) without the use of animals. The antibodies are created using an in vitro technology, antibody phage display — an alternative to the hybridoma technology that circumvents the limitations of the immune system. Antibodies developed by antibody phage display technology use human naïve antibody gene libraries.

There are many advantages to using RecMAbs recombinant antibodies instead of traditional antibodies, according to the company, including: no requirement of sacrificing animals in an animal facility; economical production and permanent storage of DNA clones; sequence-defined antibodies allowing reproducibility in experiments; and use of a single-chain antibody fragment to reconfigure a RecMAb into a full-length IgG construct for research purposes.

Phone: 02 9698 2022
Related Products

HEMCO Safety Station

HEMCO's Safety Station is a multipurpose drench shower, eye/face wash and safety supply...

AdipoGen Life Sciences COVID-19 antiviral research compounds

AdipoGen Life Sciences' range of Small Molecule SARS-CoV-2 Inhibitors and Modulators offers...

Larodan research-grade lipids

Larodan manufactures high-purity lipids, both by extraction and purification, from natural...

  • All content Copyright © 2020 Westwick-Farrow Pty Ltd